Form 8-K - Current report:
SEC Accession No. 0001299933-12-000531
Filing Date
2012-03-01
Accepted
2012-03-01 16:40:23
Documents
2
Period of Report
2012-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_44406.htm 8-K 10685
2 EX-99.1 exhibit1.htm EX-99.1 76227
  Complete submission text file 0001299933-12-000531.txt   88001
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 12658287
SIC: 2834 Pharmaceutical Preparations